Das Suchergebnis hat sich seit Ihrer Suchanfrage verändert. Eventuell werden Dokumente in anderer Reihenfolge angezeigt.
  • Treffer 7 von 276
Zurück zur Trefferliste

The Long-Term Impact of Early Life Poverty on Orbitofrontal Cortex Volume in Adulthood: Results from a Prospective Study Over 25 Years

  • Converging evidence has highlighted the association between poverty and conduct disorder (CD) without specifying neurobiological pathways. Neuroimaging research has emphasized structural and functional alterations in the orbitofrontal cortex (OFC) as one key mechanism underlying this disorder. The present study aimed to clarify the long-term influence of early poverty on OFC volume and its association with CD symptoms in healthy participants of an epidemiological cohort study followed since birth. At age 25 years, voxel-based morphometry was applied to study brain volume differences. Poverty (0 = non-exposed (N = 134), I = exposed (N = 33)) and smoking during pregnancy were determined using a standardized parent interview, and information on maternal responsiveness was derived from videotaped mother infant interactions at the age of 3 months. CD symptoms were assessed by diagnostic interview from 8 to 19 years of age. Information on life stress was acquired at each assessment and childhood maltreatment was measured using retrospectiveConverging evidence has highlighted the association between poverty and conduct disorder (CD) without specifying neurobiological pathways. Neuroimaging research has emphasized structural and functional alterations in the orbitofrontal cortex (OFC) as one key mechanism underlying this disorder. The present study aimed to clarify the long-term influence of early poverty on OFC volume and its association with CD symptoms in healthy participants of an epidemiological cohort study followed since birth. At age 25 years, voxel-based morphometry was applied to study brain volume differences. Poverty (0 = non-exposed (N = 134), I = exposed (N = 33)) and smoking during pregnancy were determined using a standardized parent interview, and information on maternal responsiveness was derived from videotaped mother infant interactions at the age of 3 months. CD symptoms were assessed by diagnostic interview from 8 to 19 years of age. Information on life stress was acquired at each assessment and childhood maltreatment was measured using retrospective self-report at the age of 23 years. Analyses were adjusted for sex, parental psychopathology and delinquency, obstetric adversity, parental education, and current poverty. Individuals exposed to early life poverty exhibited a lower OFC volume. Moreover, we replicated previous findings of increased CD symptoms as a consequence of childhood poverty. This effect proved statistically mediated by OFC volume and exposure to life stress and smoking during pregnancy, but not by childhood maltreatment and maternal responsiveness. These findings underline the importance of studying the impact of early life adversity on brain alterations and highlight the need for programs to decrease income-related disparities.zeige mehrzeige weniger

Metadaten exportieren

Weitere Dienste

Suche bei Google Scholar Statistik - Anzahl der Zugriffe auf das Dokument
Metadaten
Verfasserangaben:Nathalie E. Holz, Regina Boecker-Schlier, Erika Hohm, Katrin Zohsel, Arlette F. Buchmann, Dorothea Blomeyer, Christine Jennen-Steinmetz, Sarah Baumeister, Sarah Hohmann, Isabella Wolf, Michael M. Plichta, Günter EsserORCiDGND, Martin Schmidt, Andreas Meyer-Lindenberg, Tobias BanaschewskiORCiD, Daniel Brandeis, Manfred LauchtGND
DOI:https://doi.org/10.1038/npp.2014.277
ISSN:0893-133X
ISSN:1740-634X
Pubmed ID:https://pubmed.ncbi.nlm.nih.gov/25315195
Titel des übergeordneten Werks (Englisch):Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology
Verlag:Nature Publ. Group
Verlagsort:London
Publikationstyp:Wissenschaftlicher Artikel
Sprache:Englisch
Jahr der Erstveröffentlichung:2015
Erscheinungsjahr:2015
Datum der Freischaltung:27.03.2017
Band:40
Ausgabe:4
Seitenanzahl:9
Erste Seite:996
Letzte Seite:1004
Fördernde Institution:German Research Foundation [DFG LA 733/1-2]; Lilly; Medice; Novartis; Shire; AstraZeneca; Hoffmann-La Roche; Lundbeck Foundation; Pfizer Pharma; Lilly Deutschland; Glaxo SmithKline; Janssen Cilag; Bristol-Myers Squibb; Lundbeck
Organisationseinheiten:Humanwissenschaftliche Fakultät / Strukturbereich Kognitionswissenschaften / Department Psychologie
Peer Review:Referiert
Name der Einrichtung zum Zeitpunkt der Publikation:Humanwissenschaftliche Fakultät / Institut für Psychologie
Verstanden ✔
Diese Webseite verwendet technisch erforderliche Session-Cookies. Durch die weitere Nutzung der Webseite stimmen Sie diesem zu. Unsere Datenschutzerklärung finden Sie hier.